» Articles » PMID: 31192260

Exosomes Derived from Human Bone Marrow Mesenchymal Stem Cells Stimulated by Deferoxamine Accelerate Cutaneous Wound Healing by Promoting Angiogenesis

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2019 Jun 14
PMID 31192260
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

The exosomes are derived from mesenchymal stem cells (MSCs) and may be potentially used as an alternative for cell therapy, for treating diabetic wounds, and aid in angiogenesis. This study, aimed to investigate whether exosomes originated from bone marrow-derived MSCs (BMSCs) preconditioned by deferoxamine (DFO-Exos) exhibited superior proangiogenic property in wound repair and to explore the underlying mechanisms involved. Human umbilical vein endothelial cells (HUVECs) were used for assays involving cell proliferation, scratch wound healing, and tube formation. To test the effects in vivo, streptozotocin-induced diabetic rats were established. Two weeks after the procedure, histological analysis was used to measure wound-healing effects, and the neovascularization was evaluated as well. Our findings demonstrated that DFO-Exos activate the PI3K/AKT signaling pathway via miR-126 mediated PTEN downregulation to stimulate angiogenesis in vitro. This contributed to enhanced wound healing and angiogenesis in streptozotocin-induced diabetic rats in vivo. Our results suggest that, in cell-free therapies, exosomes derived from DFO preconditioned stem cells manifest increased proangiogenic ability.

Citing Articles

Identification of key miRNAs and target genes in extracellular vesicles derived from low-intensity pulsed ultrasound-treated stem cells.

Yin X, Yi J, Mao F, Tang Q, Zhang X, Yang X Front Genet. 2025; 15:1407671.

PMID: 39882071 PMC: 11774887. DOI: 10.3389/fgene.2024.1407671.


Mechanism and application prospect of ferroptosis inhibitors in improving osteoporosis.

Wang J, Chen T, Gao F Front Endocrinol (Lausanne). 2024; 15:1492610.

PMID: 39735645 PMC: 11671246. DOI: 10.3389/fendo.2024.1492610.


Exosomes derived from minor salivary gland mesenchymal stem cells: a promising novel exosome exhibiting pro-angiogenic and wound healing effects similar to those of adipose-derived stem cell exosomes.

Xiang H, Ding P, Qian J, Lu E, Sun Y, Lee S Stem Cell Res Ther. 2024; 15(1):462.

PMID: 39627883 PMC: 11616330. DOI: 10.1186/s13287-024-04069-5.


The role of Q10 engineering mesenchymal stem cell-derived exosomes in inhibiting ferroptosis for diabetic wound healing.

Yang R, Zhou S, Huang J, Kang D, Chen Y, Wang X Burns Trauma. 2024; 12:tkae054.

PMID: 39600692 PMC: 11596300. DOI: 10.1093/burnst/tkae054.


Signaling pathways activated and regulated by stem cell-derived exosome therapy.

Li D, Li D, Wang Z, Li J, Shahzad K, Wang Y Cell Biosci. 2024; 14(1):105.

PMID: 39164778 PMC: 11334359. DOI: 10.1186/s13578-024-01277-7.


References
1.
Lioupis C . Effects of diabetes mellitus on wound healing: an update. J Wound Care. 2005; 14(2):84-6. DOI: 10.12968/jowc.2005.14.2.26738. View

2.
Mu D, Chang Y, Vexler Z, Ferriero D . Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp Neurol. 2005; 195(2):407-15. DOI: 10.1016/j.expneurol.2005.06.001. View

3.
Amariglio N, Hirshberg A, Scheithauer B, Cohen Y, Loewenthal R, Trakhtenbrot L . Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009; 6(2):e1000029. PMC: 2642879. DOI: 10.1371/journal.pmed.1000029. View

4.
Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B . Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009; 2(100):ra81. DOI: 10.1126/scisignal.2000610. View

5.
Herberts C, Kwa M, Hermsen H . Risk factors in the development of stem cell therapy. J Transl Med. 2011; 9:29. PMC: 3070641. DOI: 10.1186/1479-5876-9-29. View